Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small ...

Researchers led by Université de Montréal pathology and cell-biology professor Marc Therrien have identified major structural ...

The RNA Targeting Small Molecule Drug Discovery Market is poised for growth, driven by demand for treatments targeting cancer ...

Phil Lambert, Ph.D., chief scientific officer of Satellos Bioscience Inc., explains the mechanism of action of the company's experimental Duchenne muscular dystrophy drug, SAT-3247, and the thinking ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

Satellos Bioscience's experimental small-molecule drug for Duchenne muscular dystrophy is showing positive results as a stand-alone treatment, but Phil Lambert, Ph.D., the company's chief scientific ...

The partnership will include $105m upfront to Orionis, with the potential for further payments that could exceed $2bn.

President Trump’s executive order aims to bring down drug prices while optimizing IP protections, and Congress should pass ...

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of ...

Lonza has launched its new Design2Optimize platform to enhance process development and manufacturing of small molecule APIs.

The biologic excipients market has become a vital component of the pharmaceutical and biotechnology industries, playing a crucial role in the formulation of biologic drugs. These excipients are ...

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it has been awarded a contract from Aspera Biomedicines, Inc. (Aspera), a ...